Evidence map›Paper›PMID 31799875›Full record

Trial reportAJR. American journal of roentgenology2020

Assessment of Response to Neoadjuvant Therapy Using CT Texture Analysis in Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma.

Amir A Borhani, Rohit Dewan, Alessandro Furlan, Natalie Seiser, Amer H Zureikat, Aatur D Singhi, Brian Boone, Nathan Bahary, Melissa E Hogg, Michael Lotze and 2 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in AJR. American journal of roentgenology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Update on quantitative radiomics of pancreatic tumors.Abdominal radiology (New York) · 2022
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Amir A BorhaniDepartment of Radiology, Division of Abdominal Imaging, University of Pittsburgh Medical Center, Ste 200 E Wing, 200 Lothrop St, Pittsburgh, PA 15213.
Rohit DewanDepartment of Radiology, Division of Abdominal Imaging, University of Pittsburgh Medical Center, Ste 200 E Wing, 200 Lothrop St, Pittsburgh, PA 15213.
Alessandro FurlanDepartment of Radiology, Division of Abdominal Imaging, University of Pittsburgh Medical Center, Ste 200 E Wing, 200 Lothrop St, Pittsburgh, PA 15213.
Natalie SeiserDepartment of Surgery, Division of Gastrointestinal Surgical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Amer H ZureikatDepartment of Surgery, Division of Gastrointestinal Surgical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Aatur D SinghiDepartment of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Brian BooneDepartment of Surgery, Division of Gastrointestinal Surgical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Nathan BaharyDepartment of Medicine, Division of Hematology/Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Melissa E HoggDepartment of Surgery, Division of Gastrointestinal Surgical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Michael LotzeDepartment of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Herbert J ZehDepartment of Surgery, Division of Gastrointestinal Surgical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Mitchell E TublinDepartment of Radiology, Division of Abdominal Imaging, University of Pittsburgh Medical Center, Ste 200 E Wing, 200 Lothrop St, Pittsburgh, PA 15213.

Funding

University of Pittsburgh Clinical and Translational Science InstituteUL1TR001857 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2016 to 2025
$129.3M
West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI JUDITH FEINBERG · 2012 to 2026
$81.0M
Pancreatic Ductal Adenocarcinoma is a disease of constitutive autophagyR01CA181450 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LOTZE, MICHAEL T, ZEH, HERBERT J · 2014 to 2018
$1.6M
NCATS NIH HHS UL1 TR001857NCI NIH HHS R01 CA181450NIGMS NIH HHS U54 GM104942
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Radiographic Image Interpretation, Computer-AssistedTomography, X-Ray ComputedAdultAgedAged, 80 and overCarcinoma, Pancreatic DuctalContrast MediaDisease-Free SurvivalFemaleHumansIopamidolMaleMiddle AgedNeoadjuvant TherapyNeoplasm GradingPancreatic NeoplasmsContrast MediaIopamidolCTneoadjuvant chemotherapypancreatic adenocarcinomapancreatic cancertexture analysis

Identifiers

PMID31799875
PMCPMC7457395

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.